Tricarballylic ester formation during biosynthesis of fumonisin mycotoxins in \u3ci\u3eFusarium verticillioides\u3c/i\u3e by Li, Yaoyao et al.
University of Nebraska - Lincoln
DigitalCommons@University of Nebraska - Lincoln
Liangcheng Du Publications Published Research - Department of Chemistry
March 2016
Tricarballylic ester formation during biosynthesis of
fumonisin mycotoxins in Fusarium verticillioides
Yaoyao Li
University of Nebraska-Lincoln
Lili Lou
University of Nebraska-Lincoln
Ronald Cerny
University of Nebraska-Lincoln, rcerny1@unl.edu
Robert A.E. Butchko
USDA-ARS, Peoria, IL, rbutchko@aggienetwork.com
Robert H. Proctor
USDA-ARS, Peoria, IL, robert.proctor@ars.usda.gov
See next page for additional authors
Follow this and additional works at: http://digitalcommons.unl.edu/chemistrydu
This Article is brought to you for free and open access by the Published Research - Department of Chemistry at DigitalCommons@University of
Nebraska - Lincoln. It has been accepted for inclusion in Liangcheng Du Publications by an authorized administrator of DigitalCommons@University
of Nebraska - Lincoln.
Li, Yaoyao; Lou, Lili; Cerny, Ronald; Butchko, Robert A.E.; Proctor, Robert H.; Shen, Yuemao; and Du, Liangcheng, "Tricarballylic
ester formation during biosynthesis of fumonisin mycotoxins in Fusarium verticillioides" (2016). Liangcheng Du Publications. 11.
http://digitalcommons.unl.edu/chemistrydu/11
Authors
Yaoyao Li, Lili Lou, Ronald Cerny, Robert A.E. Butchko, Robert H. Proctor, Yuemao Shen, and Liangcheng
Du
This article is available at DigitalCommons@University of Nebraska - Lincoln: http://digitalcommons.unl.edu/chemistrydu/11
Tricarballylic ester formation during biosynthesis of fumonisin mycotoxins in Fusarium
verticillioides
Yaoyao Lia,b, Lili Loua, Ronald L. Cernya, Robert A.E. Butchkoc, Robert H. Proctorc, Yuemao Shenb and Liangcheng Dua*
aDepartment of Chemistry, University of Nebraska-Lincoln, Lincoln, NE 68588, USA; bSchool of Pharmaceutical Sciences, Shandong
University, Jinan 250100, China; cNational Center for Agriculture Utilization Research, ARS-USDA, 1815 North University Street,
Peoria, IL 61604, USA
(Received 1 November 2013; accepted 8 December 2013)
Fumonisins are agriculturally important mycotoxins produced by the maize pathogen Fusarium verticillioides. The
chemical structure of fumonisins contains two tricarballylic esters, which are rare structural moieties and important for
toxicity. The mechanism for the tricarballylic ester formation is not well understood. FUM7 gene of F. verticillioides was
predicted to encode a dehydrogenase/reductase, and when it was deleted, the mutant produced tetradehydro fumonisins
(DH4–FB). MS and NMR analysis of DH4–FB1 indicated that the esters consist of aconitate with a 3′-alkene function, rather
than a 2′-alkene function. Interestingly, the purified DH4–FB1 eventually yielded three chromatographic peaks in HPLC.
However, MS revealed that the metabolites of the three peaks all had the same mass as the initial single-peak DH4–FB1. The
results suggest that DH4–FB1 can undergo spontaneous isomerization, probably including both cis–trans stereoisomeriza-
tion and 3′- to 2′-ene regioisomerization. In addition, when FUM7 was expressed in Escherichia coli and the resulting
enzyme, Fum7p, was incubated with DH4–FB, no fumonisin with typical tricarballylic esters was formed. Instead, new
fumonisin analogs that probably contained isocitrate and/or oxalosuccinate esters were formed, which reveals new insight
into fumonisin biosynthesis. Together, the data provided both genetic and biochemical evidence for the mechanism of
tricarballylic ester formation in fumonisin biosynthesis.
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1. Introduction
Fumonisins are a group of mycotoxins produced by sev-
eral agriculturally important fungi, including Fusarium
verticillioides (synonym F. moniliforme, teleomorph
Gibberella moniliformis, synonym G. fujikuroi mating
population A), which is a common fungal contaminant
of maize and maize-derived products worldwide
(Marasas et al. 2004; Wang et al. 2006, 2008). The fungus
can cause ear, stalk, and seedling rots of maize, and can
also occur at a high frequency in healthy corn tissues
(Miller 2001). Fumonisin contamination in maize has
been associated with diseases in some livestock and with
human health problems, including esophageal cancer and
neural tube defects (Marasas et al. 2004).
At least 28 fumonisin analogs have been characterized
(Rheeder et al. 2002). The B-series fumonisins, FB1, FB2,
FB3, and FB4, are the predominant analogs produced by
wild-type isolates of F. verticillioides (Figure 1, FB1 struc-
ture shown) (Nelson et al. 1993). The metabolites contain
a linear 18-carbon chain (C-3 to C-20) that is synthesized
from acetate by the activity of an iterative polyketide
synthase (Fum1p) (Proctor et al. 1999; Zhu et al. 2007;
Du et al. 2008). The amino group and C-1 and C-2 are
derived from alanine (Branham and Plattner 1993;
Blackwell et al. 1996; Gerber et al. 2009). The two methyl
groups at C-12 and C-16 are derived from methionine
(Plattner and Shackelford 1992). In FB1, the hydroxyl
groups at C-5, C-10, C-14, and C-15 are derived from
molecular oxygen and are formed following synthesis of
the polyketide (Caldas et al. 1998; Ding et al. 2004;
Proctor et al. 2006), while the C-3 hydroxyl originates
from acetate and results from reduction of a 3-keto group
(Butchko et al. 2003; Yi et al. 2005). The condensation
between the 18-carbon chain and alanine involves a
unique polyketide chain-releasing mechanism (Du et al.
2008; Gerber et al. 2009).
Another unusual modification during fumonisin bio-
synthesis is esterification of tricarballylic moieties to the
C-14 and C-15 hydroxyls. Tricarballylic esters are rare
structural features in natural products and are necessary
for fumonisin toxicity (Yin et al. 1996; Humpf et al. 1998;
Seefelder et al. 2003). The molecular mechanism by
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which fumonisin tricarballylic esters are formed has
not been fully elucidated. Previous studies using
13C-substrates suggested that the precursor for the tricar-
ballylic esters is an intermediate from the citric acid cycle
(Blackwell et al. 1996). Data obtained from gene-deletion
mutants of F. verticillioides suggest that four genes,
FUM7, FUM10, FUM11, and FUM14, are required for
the formation of esters (Butchko et al. 2006; Zaleta-Rivera
et al. 2006). FUM7 is predicted to encode an iron-contain-
ing dehydrogenases/reductases, similar to those that cata-
lyze the reversible reduction of an alkene to an alkane
(Seibert et al. 1998; Kallberg et al. 2002). FUM7-deletion
mutants produce FB analogs with an alkene function in
both esters (tetradehydro-FB, DH4–FB) (Figure 1)
(Butchko et al. 2006). This suggests that the enzyme
(Fum7p) encoded by FUM7 is likely to catalyze reduction
of the alkene. In order to determine the regio- and stereo-
specificity of this biosynthetic step, we prepared the pre-
dominant component (DH4–FB1) and determined the posi-
tions of the carbon–carbon double bond in tricarballylate.
We also investigated the alkene reductase activity of
Fum7p through heterologous expression.
2. Materials and methods
2.1. Materials and general methods
Chemicals were purchased from Fisher Scientific or
Sigma. All oligonucleotide primers for PCR were synthe-
sized by Integrated DNA Technologies (IDT; Coralville,
IA). Escherichia coli strain DH5α was used as the host for
general plasmid DNA propagation, and cloning vectors
were the pGEM-zf series from Promega (Madison, WI).
Plasmid preparation and DNA extraction were carried out
using Qiagen kits (Valencia, CA), and all other DNA
manipulations were carried out according to standard
methods (Sambrook et al. 1989).
2.2. Isolation and analysis of fumonisin analogs from
F. verticillioides
Procedures for isolating the B-series fumonisins from F.
verticillioides were essentially same as described previously
(Bojja et al. 2004). For isolating and analyzing the tetra-
dehydro tricarballylate-containing analogs from the FUM7
mutant, the procedure was modified as follows. Single
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Figure 1. Chemical structure of fumonisins and analogs. DH4–FB1, tetradehydro fumonisin B1. (A) Structure of fumonism B1 and
tetradehydro fumonism B1. (B) Example of possible regio- and sterioisomers of DH4–FB1.
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colonies of the fungus growing on YPD/hygromycin
(300 μg/ml) agar medium were transferred to test tubes
containing 3 ml YPD/hygromycin (150 μg/ml) liquid med-
ium and allowed to grow in a shaker (60 rpm) at room
temperature for 2 days. From the 3 ml culture, 100 μl was
transferred to a flask containing 25 ml YPD/hygromycin
(150 μg/ml). The culture was incubated with shaking at
room temperature for another 2 days. The culture was
transferred to a 50-ml tube and centrifuged at 2500 rpm
for 20 min. The pellet was washed three times with sterile
water and finally re-suspended in 10 ml sterile water. From
the suspended solution, 500 μl was transferred to a new
flask containing 10 g of autoclaved Cracked Maize Kernel
(CMK) medium (Proctor et al. 2003). After 4 weeks of
growth at room temperature in the dark, metabolites were
extracted from the CMK cultures with 20 ml of 50%
acetonitrile (CH3CN). An aliquot of the extracts was filtered
and a sample of 50 μl was injected in HPLC-ELSD to
analyze the metabolites, following the method described
previously (Bojja et al. 2004).
To prepare DH4–FB1 for spectroscopic studies, the
crude extract was dried and partitioned into EtOAc-solu-
ble and H2O-soluble extracts. The H2O extract was loaded
onto a 10-g C18 cartridge and eluted with the stepwise
gradient of 0, 15%, 30%, 50%, and 70% CH3CN in H2O
(containing 0.025% TFA, 100 ml for each step). The 30%
CH3CN fraction was loaded onto another 10-g C18
cartridge and eluted with the stepwise gradient of 15%,
25%, and 35% CH3CN in H2O (containing 0.025% TFA,
100 ml for each step). The 35% CH3CN fraction (280 mg)
was subjected to a gel permeation chromatography (50 g
Sephadex LH-20, in methanol) for further purification.
Purified DH4–FB1 was analyzed by ESI-MS on an API
Qtrap 4000 and NMR spectra (1H- and 13C-NMR and
HMBC) on a Bruker DRX-500 spectrometer, at 500/
125 MHz, respectively, in methanol-d6, δ in ppm relative
to Me4Si, J in Hz.
2.3. FUM7 gene expression and enzyme purification
FUM7 has no introns (Proctor et al. 2003) and was ampli-
fied directly from the genomic DNA of F. verticillioides by
PCR using a forward primer of 5′-C TCT AGA CAT ATG
AGT CTT GAT CAT CAC CAG-3′ (NdeI site underlined)
and a reverse primer of 5′-CCC AAG CTT CTATGC TGC
CAT GTA CAG-3′ (HindIII site underlined). After the
identity of the 1275 bp fragment was confirmed by DNA
sequencing, it was cloned into pET28a for expression in E.
coli BL21(DE3) and pMAL-c2 for expression in E. coli
TB1 as specified by the manufacturers. Fum7p was highly
expressed in both systems, but only the TB1/pMAL-c2
system yielded a soluble protein. The soluble fraction of
the expressed protein was loaded onto an amylose resin
column (New England BioLabs) for affinity purification of
the protein. The purified protein was desalted by dialysis
against a buffer containing 50 mM Tris–HCl, pH 7.8,
100 mM NaCl, 10 mM MgCl2, 2 mM dithiothreitol, and
15% glycerol. The resulting preparation was stored at –80°
C until it was used in assays.
2.4. In vitro activity assay for Fum7p
The reactions contained 0.4 µM Fum7p, 2.8 mM DH4–
FB, 1 mM NAD(P)H, 1 mM FeCl2, and 100 mM Tris–
HCl, pH 7.8, in a total volume of 100 µl. The reactions
were incubated at 37°C for 30 min and stopped by adding
two volumes of ethanol at 4°C. After 30 min on ice, the
precipitated proteins were removed by centrifugation at
13,200 rpm at 4°C for 20 min, and the supernatant was
transferred to a new tube. A 100 μl fraction of supernatant
was used for HPLC–ELSD and ESI–MS analysis.
3. Results and discussion
3.1. Position and configuration of the alkene in
tricarballylic esters of DH4–FB1
FUM7 mutants of F. verticillioides produce fumonisin
analogs, tetradehydro fumonisins (DH4–FBs), that are
four mass units less ([M + H]+ m/z 718 and m/z 702)
than FB1 (m/z 722) or FB2/3 (m/z 706) (Butchko et al.
2006). The difference in mass between DH4–FBs and FBs
is due to an alkene function present in each of the two
tricarballylate esters of DH4–FBs. However, the position
and configuration of the alkene function are not clear, as
multiple regio- and stereoisomers of aconitate could
account for the difference (Figure 1). We therefore set
out to determine the structure of tricarballylate esters in
DH4–FB. After several purification steps, we were able to
obtain DH4–FB1 that yielded as a single chromatographic
peak in HPLC analysis (Figure 2). MS analysis confirmed
a [M + H]+ m/z 718.4 for the purified DH4–FB1, and
1H-
NMR analysis was consistent with one major compound.
The position of the carbon–carbon double bond in the
tricarballylic esters of DH4–FB1 was identified by spectro-
scopic analyses, including 1D- and 2D-NMR data
(Table 1), and by comparison of these data to those
previously published for fumonisins (Bezuidenhout et al.
1988). The selected HMBC corrections from H-15 to C-22
and C-29; H-30/24 to C-29/23 and C-34/28; and H-32/26
to C-30/24, C-33/27, and C-34/28 established the tricar-
ballylic ester on the C-15 hydroxyl with a double bond
between C-31 and C-32 (3′-ene) and the tricarballylic ester
on the C-14 hydroxyl with a double bond between C-25
and C-26 (3′-ene) (Table 1 and Figure 1).
Interestingly, when the purified DH4–FB1 was incu-
bated at room temperature for 2 days, additional chroma-
tographic peaks were observed in the sample in HPLC
analysis. To exclude potential degradation products, we
attempted to further separate the preparation using a gel
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Figure 2. Isolation and analysis of DH4–FB1 from the FUM7 mutant. (A) HPLC analysis of crude extract; (B) HPLC analysis of the
initially purified DH4–FB1; (C) HPLC analysis of the isomerized DH4–FB1; (D) MS analysis of the initially purified DH4–FB1; and
(E) MS analysis of the isomerized DH4–FB1. A proposed cis–trans stereoisomerization of DH4–FB1 is included.
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permeation chromatography (Sephadex LH-20).
Surprisingly, the DH4–FB1 fraction continued to yield
three major chromatographic peaks, instead of one peak,
in HPLC analysis, but yielded only one signal [M + H]+
m/z 718.4, in MS analysis (Figure 2). These results indi-
cate that the three peaks in the preparation represent three
isomers of DH4–FB1. One probable explanation for for-
mation of the isomers is that the original preparation of
purified single 3′,3′-diene stereoisomer of DH4–FB1 was
converted to other cis–trans stereoisomers (Figure 2) and/
or 2′-ene regioisomers during the 2-day incubation period.
For the didehydrotricarballylate (aconitate) moieties of
DH4–FB1, both regio- and stereoisomerization could
occur either through a C-3′ to C-4′ bond rotation of the
aconitate carbonium ion following a protonation of the
double bond from an acid and then deprotonation, or
through an allylic rearrangement by elimination of a pro-
ton at C-2′ of the aconitate carbonium ion (Klinman and
Rose 1971). These mechanisms are reasonable consider-
ing that all DH4–FB1 solvents contained an acid (0.025%
TFA). These results are also consistent with the previous
study that observed broad NMR peaks for the tricar-
ballylic carbons in DH4–FB (Butchko et al. 2006).
3.2. Activity of heterologously expressed Fum7p
Previous in vivo feeding experiments suggested that the
tetradehydro fumonisins (DH4–FB) produced by FUM7-
deletion mutants of F. verticillioides are probably shunt
metabolites of the biosynthetic pathway, because strains of
the fungus with a wild-type FUM7 were unable to convert
the DH4–FB into FB (Butchko et al. 2006). To obtain
direct evidence, we heterologously expressed FUM7 and
examined whether purified Fum7p could catalyze conver-
sion of DH4–FB to FB in vitro. Fum7p produced in the
TB2/pMALc2 expression system was partly soluble as a
fusion protein with MBP. The protein purified on an
amylose affinity column yielded approximately 88.2 kDa
band on SDS–PAGE (Figure 3), which is consistent with
the expected size for the fusion protein. Fum7p was incu-
bated with purified DH4–FB in the presence of NADPH
and Fe2+, which are cofactors usually required for activity
of the class of dehydrogenases/reductases to which Fum7p
is most similar (Seibert et al. 1998; Kallberg et al. 2002).
The MS analysis of the reaction mixtures showed that
fumonisins with typical tricarballylic esters were not pro-
duced and that the [M + H]+ ions of 718.43 (DH4–FB1)
and 702.42 (DH4–FB2/3) remained in the reaction mix-
tures, under the conditions tested (Figure 4). The results
are consistent with the in vivo feeding experiments
(Butchko et al. 2006) and suggest that free DH4–FB are
not direct substrates of Fum7p. Interestingly, although
fumonisins with typical tricarballylic esters were not
detected, several novel metabolites were produced in the
reactions. One (compound 1) of these had a molecular ion
of 750.33, which is the same as that expected for an FB1
analog with two oxalosuccinate esters (Figures 4 and 5).
Another novel metabolite (compound 3) had a molecular
ion of 754.33, which is consistent with an FB1 analog with
two isocitrate (or citrate) esters. Finally, a third metabolite
(compound 2) with a molecular ion of 752.35, which is
the same as that expected for an FB1 analog with one
isocitrate (or citrate) ester and one oxalosuccinate ester.
These ions were not present in the initial DH4–FB isolated
Table 1. Selected HMBC correlations (H→C) for DH4–FB1
and 1H–NMR (500 MHz) and 13C–NMR (125 MHz) spectro-
scopic data (methanol-d4) for DH4–FB1. δ in ppm. J in Hz.
O
O
O
14
15
22
29 31
34O OH
OH
O
33
H C
Position δ(H), (multiplicity, J in Hz) δ(C)
14 5.10 (m) 71.8 (d)
15 4.91 (m) 78.2 (d)
22 0.93 (d, J = 6.9) 14.6 (q)
23/29a – 170.6 (s)
24/30a 3.98 (m) 33.4 (t)
3.93 (m)
25/31a – 139.1 (s)
26/32a 6.94 (s) 130.2 (d)
27/33a – 168.5 (s)b
28/34a – 168.4 (s)b
Notes: aThe chemical shift for each of the pairs could not be assigned
specifically, due to the weak and contaminated signals in NMR spectra.
bMay be interchanged.
1 2 kDa
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130
95
72
55
43
34
26
Fum7p
88.2kDa
Figure 3. SDS-PAGE of Fum7p produced in E. coli. Lane 1,
purified Fum7p; Lane 2, size markers.
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from the FUM7-deleted mutant. Interestingly, these ions
were present, but at a lower level, in the reaction mixture
containing boiled Fum7p. When NADH was used in the
place of NADPH, the intensity of the ions was signifi-
cantly reduced (Figure 4). The results suggest that Fum7p
promotes the conversion of DH4–FB into analogs with
isocitrate (or citrate) and oxalosuccinate side chains. This
conversion could be realized through a hydration of aco-
nitate to generate isocitrate (or citrate), followed by a
dehydrogenation of isocitrate to produce oxalosuccinate
(Figure 5). The hydration could be a non-enzymatic step,
whereas the dehydrogenation should be facilitated by the
dehydrogenase activity of Fum7p.
3.3. Mechanism for the tricarballylic ester formation
Previous studies have shown that FUM7, FUM10,
FUM11, and FUM14 are involved in formation of the
tricarballylic esters of fumonisins (Butchko et al. 2006;
Zaleta-Rivera et al. 2006). Among the four genes, the
function of FUM14 has been demonstrated both in vivo
and in vitro (Butchko et al. 2006; Zaleta-Rivera et al.
2006). FUM14 is predicted to encode an unusual nonri-
bosomal peptide synthetase (NRPS) containing two
domains, peptidyl carrier protein (PCP) and condensation
domain. Fum14p catalyzes the transfer of the activated
tricarballylic acid to the hydroxyl groups on C-14 and
C-15 to form the two ester bonds. FUM10-deletion
mutants produce hydrolyzed FB3 and FB4 (HFB3 and
HFB4, respectively), analogs of FB3 and FB4 that lack
the esters (Butchko et al. 2006). FUM10 is predicted to
encode an acyl-CoA synthetase or the adenylation domain
of NRPS (Proctor et al. 2003). Therefore, FUM10 is likely
responsible for in vivo activation of the tricarballylic acid.
FUM11-deletion mutants produce the wild-type comple-
ment of fumonisins as well as a significant amount of
partially hydrolyzed fumonisins, fumonisin analogs that
lack one of the ester functions (Butchko et al. 2006).
FUM11 is predicted to encode a tricarboxylate transporter
and is likely to function in vivo to supply the tricarboxylic
acid precursors for esterification (Proctor et al. 2003). Two
lines of evidence support its involvement of FUM7 in the
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Figure 4. MS analysis of the reaction mixtures containing Fum7p and tetradehydro fumonisins. (A) Standard fumonisins;
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and one isocitrate ester; and 3, fumonisin analog with two isocitrate esters.
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tricarballylic ester formation. First, FUM7 mutants pro-
duce DH4–FBs with an alkene function in both esters
rather than the wild-type complement of FBs (Butchko
et al. 2006). Second, the deduced amino acid sequence
of FUM7 is most similar to a class of dehydrogenases/
reductases that catalyze alkene-to-alkane reductions
(Seibert et al. 1998; Kallberg et al. 2002). Given the
evidence, it makes sense to propose that Fum7p catalyzes
the hydrogenation of DH4–FB to form FB (Du et al. 2008;
Huffman et al. 2010). However, the regio- and stereo-
specificity of the reduction was not clear. In addition, the
timing of the reduction remained unknown, because the
reduction could take place after the DH4–FB product has
been released from the carrier domain (PCP) of Fum14p,
or the reduction could take place while aconitate is still
covalently linked to the PCP after the substrate has been
activated by Fum10p and loaded to the PCP of Fum14p
(Figure 5). In this study, we have determined the position
of the carbon–carbon double bond in DH4–FB1, the pre-
dominant DH4–FB produced by FUM7 mutants of F.
verticillioides. In addition, our results indicate that alkene
function in the tricarballylic esters of DH4–FB1 undergo
isomerization that leads to the formation of a mixture of
regio- and stereoisomers. If this isomerization occurs in
vivo, it seems probable that Fum7p would have a broad
specificity to reduce the mixture into regular fumonisins
with saturated tricarballylate esters, because wild-type F.
verticillioides does not produce DH4–FBs. Furthermore,
the results of the heterologous expression of FUM7 and
assessment of in vitro activity of the resulting enzyme
suggest that the Fum7p-catalyzed reduction reaction most
likely takes place while the aconitate substrate is cova-
lently linked to the PCP of Fum14p enzyme.
In conclusion, this work provides molecular insights
into the biosynthetic mechanism of the rare structural
moieties of fumonisins. Because the toxicity of DH4–
FBs relative to FBs is not known and tricarballylic ester-
ification is an essential step for the maturation of the
mycotoxins, an understanding of the complexity of this
process is useful for efforts in agriculture to reduce myco-
toxin contamination.
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